Russell Frank Company’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-53
Closed -$223K 2898
2013
Q3
$223K Sell
53
-130
-71% -$547K ﹤0.01% 2734
2013
Q2
$616K Buy
+183
New +$616K ﹤0.01% 2256